9J4H

Crystal structure of SHMT apo form

9J4H の概要

• エントリーDOI: 10.2210/pdb9j4h/pdb
• 分子名称: Serine hydroxymethyltransferase, TRIETHYLENE GLYCOL (3 entities in total)
• 機能のキーワード: one carbon metabolism, apo enzyme plp, transferase
• 由来する生物種: Enterococcus faecium
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 181533.30

構造登録者

Murayama, K.,Hayashi, H. (登録日: 2024-08-09, 公開日: 2024-10-09)

主引用文献

Hayashi, H.,Saijo, E.,Hirata, K.,Murakami, S.,Okuda, H.,Kodama, E.N.,Hasegawa, K.,Murayama, K.
SHIN-2 exerts potent activity against VanA-type vancomycin-resistant Enterococcus faecium in vitro by stabilizing the active site loop of serine hydroxymethyltransferase.
Arch.Biochem.Biophys., 761:110160-110160, 2024

PubMed Abstract: Novel classes of antibiotics are needed to improve the resilience of the healthcare system to antimicrobial resistance (AMR), including vancomycin resistance. vanA gene cluster is a cause of vancomycin resistance. This gene cluster is transferred and spreads vancomycin resistance from Enterococcus spp. to Staphylococcus aureus. Therefore, novel antibacterial agents are required to combat AMR, including vanA-type vancomycin resistance. Serine hydroxymethyltransferase (SHMT) is a key target of antibacterial agents. However, the specific binding mechanisms of SHMT inhibitors remain unclear. Detailed structural information will contribute to understanding these mechanisms. In this study, we found that (+)-SHIN-2, the first in vivo active inhibitor of human SHMT, is strongly bound to the Enterococcus faecium SHMT (efmSHMT). Comparison of the crystal structures of apo- and (+)-SHIN-2-boud efmSHMT revealed that (+)-SHIN-2 stabilized the active site loop of efmSHMT via hydrogen bonds, which are critical for efmSHMT inhibition. Additionally, (+)-SHIN-2 formed hydrogen bonds with serine, forming the Schiff's base with pyridoxal 5'-phosphate, which is a co-factor of SHMT. Furthermore, (+)-SHIN-2 exerted biostatic effects on vancomycin-susceptible and vanA-type vancomycin-resistant E. faecium in vitro, indicating that SHMT inhibitors do not induce cross-resistance to vanA-type vancomycin. Overall, these findings can aid in the design of novel SHMT inhibitors to combat AMR, including vancomycin resistance.

PubMed: 39313141
DOI: 10.1016/j.abb.2024.110160

実験手法

X-RAY DIFFRACTION (2.04 Å)